Nordic Biomarker kan utses till Årets Exportsuccé

I juni fick Nordic Biomarker motta Årets teknik- och industripris på Umeågalan. Nu kan företaget vinna en ny prestigefylld utmärkelse – som Årets Exportsuccé i Sverige 2022.
– Det är verkligen superhäftigt, säger Rikard Rodén, vd för Nordic Biomarker.

Read more

Umeå company almost quadruples team as new antibody progresses to clinical trials

Umeå-based Lipum will reach an important milestone in its history this year as clinical trials begin on its antibody to treat inflammatory diseases. No less than 17 consultants are now involved in the drug’s development.
“Developing a new drug is complicated, and the process is governed by strict regulations. It is therefore important to build a competent team in and around the company. The number of employees a company has does not always tell the whole story. In reality there are often many more people needed to develop a drug”, says Pernilla Abrahamsson, Chief Operating Officer at Lipum.

Read more

Lyckad arbetsmarknadsdag – lockade över 250 besökare

Den 3 maj arrangerade Umeå Biotech Incubator en arbetsmarknadsdag, där 18 företag deltog.
Över 250 besökare kom och stämningen var god.
– Vi är väldigt nöjda med life science-mässan. Det var väldigt roligt att se så många utställare och besökare som alla var intresserade av life science. Viktigt för branschen – och viktigt för Umeå! säger Malin Walfridsson på Nordic Biomarker.

Read more

UBI organizes life science recruitment day

Umeå Biotech Incubator (UBI) is arranging a recruitment day with life science companies this May – and already 19 companies have signed up to take part.
“We want students to get in touch with us. Recruitment opportunities are everything for life science companies”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

Umeå Biotech Incubator gets EU grant extension

The life science industry in the Umeå region is on track to triple its turnover and double the number of people it employs by 2030. To help it reach this target, the Swedish Agency for Economic and Regional Growth has awarded Umeå Biotech Incubator (UBI) a grant of SEK 9.5 million.
For the next 18 months, UBI will develop meeting places and create the conditions for the continued growth of the life science industry in northern Sweden.
“We are delighted that our application has been approved! This gives us the opportunity to continue to develop the industry and contribute to the appeal of northern Sweden”, says Jennie Ekbeck, CEO of UBI.

Read more

Umeå Biotech companies raised SEK 301 Million in 2021

Companies and alumni from Umeå Biotech Incubator (UBI) raised SEK 301 million in capital investment and grants in 2021 – a huge increase of SEK 243 million compared to the previous year.
“It’s an absolutely fantastic amount. We work hard to help companies attract investment, so it is clear that our incubator process is working. Of the companies that raised money, 50 percent have a female CEO, which is extra gratifying”, says Jennie Ekbeck, CEO of UBI.

Read more

New acne medicine takes one step closer to market launch

Umeå-based pharmaceutical company Vakona has signed an agreement with French company GTP Tech to initiate the first manufacturing steps of its acne medicine.
“Production is at a level of quality that enables the medicine to be used in human clinical trials. If all goes well the medicine should be on the market within five to seven years”, says Mats Strömqvist, CEO and Chairman of the Board of Vakona.

Read more

Two more business coaches join Umeå Biotech Incubator 

Umeå Biotech Incubator (UBI) has strengthened its team with the appointment of two new business coaches – Lisandro Bernardo and Tobias Tovedal.
“There’s significant demand right now for business support, both in the early and late phases of development. We are extremely happy to welcome these two stars to our team”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

UmanDiagnostics Appoints Business Development Manager

Ylva Elias has been appointed Business Development Manager at Swedish life science company UmanDiagnostics. She formerly took up her new position in January this year, and is responsible for selling and marketing UmanDiagnostics products throughout Europe.

“This is an incredibly important recruitment for our company. Ylva has the perfect background to be able to help us reach out to new customers in our European markets”, says Niklas Norgren, CEO of UmanDiagnostics.

Read more

Breakthrough for Inficure Bio about liver and kidney fibrosis

Inficure Bio a life science company focused on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions co-presented with CymaBay Therapeutics positive data at the American Association for the study of Liver Diseases (AASLD) using the company’s proprietary NIF mouse model.

Read more

Umeå Biotech Incubator to open northern Sweden’s first life science networking pub

The northern Sweden’s first networking pub for people working in the life science industry will open its doors in Umeå on November 23rd. Behind the initiative is Umeå Biotech Incubator, which has previously been named Europe’s most innovative life science incubator.
“In Umeå we think it is important to ‘pay it forward’. We want to help and support one another and create a strong sense of unity and community. In order to succeed, we need to get to know each other”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

Multimillion SEK investment in Vakona signals start of production

Three investors are backing Umeå-based pharmaceutical company Vakona with funding worth millions of SEK.
“We are absolutely delighted and proud to have attracted this investment. It’s a reward for many years of hard work and takes us one step closer to clinical human trials”, says Gabriella Persson, CEO of Vakona.

Read more

UmanDiagnostics launches new product that can revolutionize research in neurological diseases

Swedish-based UmanDiagnostics, a Quanterix company, has developed a new type of product that makes it easier to detect neurological diseases. Called NF-light ™ serum ELISA, it was officially launched on October 12th and will now be sold worldwide.
“Our product can be used for research inthe field of neurological diseases throughout the world. It feels very exciting, because our product is clearly revolutionary”, says Niklas Norgren, VP, Managing Director and co-founder of UmanDiagnostics.

Read more